185 related articles for article (PubMed ID: 18588585)
1. Prion disease causes less severe lesions in human hippocampus than other parts of brain.
Kaneko M; Sugiyama N; Sasayama D; Yamaoka K; Miyakawa T; Arima K; Tsuchiya K; Hasegawa K; Washizuka S; Hanihara T; Amano N; Yagishita S
Psychiatry Clin Neurosci; 2008 Jun; 62(3):264-70. PubMed ID: 18588585
[TBL] [Abstract][Full Text] [Related]
2. Resistance of the hippocampus in Creutzfeldt-Jakob disease.
Masullo C; Macchi G
Clin Neuropathol; 1997; 16(1):37-44. PubMed ID: 9020394
[TBL] [Abstract][Full Text] [Related]
3. Redox metals and oxidative abnormalities in human prion diseases.
Petersen RB; Siedlak SL; Lee HG; Kim YS; Nunomura A; Tagliavini F; Ghetti B; Cras P; Moreira PI; Castellani RJ; Guentchev M; Budka H; Ironside JW; Gambetti P; Smith MA; Perry G
Acta Neuropathol; 2005 Sep; 110(3):232-8. PubMed ID: 16096758
[TBL] [Abstract][Full Text] [Related]
4. The spatial patterns of prion protein deposits in cases of variant Creutzfeldt-Jakob disease.
Armstrong RA; Cairns NJ; Ironside JW; Lantos PL
Acta Neuropathol; 2002 Dec; 104(6):665-9. PubMed ID: 12410388
[TBL] [Abstract][Full Text] [Related]
5. [A process of programmed cell death as a mechanisms of neuronal death in prion diseases].
Chrétien F; Dorandeu A; Adle-Biassette H; Ereau T; Wingertsmann L; Brion F; Gray F
Clin Exp Pathol; 1999; 47(3-4):181-91. PubMed ID: 10472738
[TBL] [Abstract][Full Text] [Related]
6. Parahippocampal pathology in Creutzfeldt-Jakob disease.
Kaneko M; Arai K; Hattori T; Imai T
Clin Neuropathol; 1999; 18(1):9-16. PubMed ID: 9988133
[TBL] [Abstract][Full Text] [Related]
7. [Gene mutation and pathology in human prion disease].
Tashiro H; Doh-ura K
No To Shinkei; 1997 Aug; 49(8):681-7. PubMed ID: 9282361
[No Abstract] [Full Text] [Related]
8. Prion disease with a 144 base pair insertion: unusual cerebellar prion protein immunoreactivity.
Gelpi E; Kovacs GG; Ströbel T; Koperek O; Voigtländer T; Liberski PP; Budka H
Acta Neuropathol; 2005 Nov; 110(5):513-9. PubMed ID: 16155763
[TBL] [Abstract][Full Text] [Related]
9. Intracerebral distribution of infectious amyloid protein in spongiform encephalopathy.
Brown P; Kenney K; Little B; Ironside J; Will R; Cervenáková L; Bjork RJ; San Martin RA; Safar J; Roos R
Ann Neurol; 1995 Aug; 38(2):245-53. PubMed ID: 7654073
[TBL] [Abstract][Full Text] [Related]
10. The epsilon isoform of 14-3-3 protein is a component of the prion protein amyloid deposits of Gerstmann-Sträussler-Scheinker disease.
Di Fede G; Giaccone G; Limido L; Mangieri M; Suardi S; Puoti G; Morbin M; Mazzoleni G; Ghetti B; Tagliavini F
J Neuropathol Exp Neurol; 2007 Feb; 66(2):124-30. PubMed ID: 17278997
[TBL] [Abstract][Full Text] [Related]
11. Cerebral amyloid angiopathy with co-localization of prion protein and beta-amyloid in an 85-year-old patient with sporadic Creutzfeldt-Jakob disease.
Paquet C; Privat N; Kaci R; Polivka M; Dupont O; Haïk S; Laplanche JL; Hauw JJ; Gray F
Acta Neuropathol; 2008 Nov; 116(5):567-73. PubMed ID: 18551298
[TBL] [Abstract][Full Text] [Related]
12. Neuropathological features of a case with schizophrenia and prion protein gene P102L mutation before onset of Gerstmann-Sträussler-Scheinker disease.
Sasaki K; Doh-ura K; Furuta A; Nakashima S; Morisada Y; Tateishi J; Iwaki T
Acta Neuropathol; 2003 Jul; 106(1):92-6. PubMed ID: 12682740
[TBL] [Abstract][Full Text] [Related]
13. Tauopathy in human and experimental variant Creutzfeldt-Jakob disease.
Giaccone G; Mangieri M; Capobianco R; Limido L; Hauw JJ; Haïk S; Fociani P; Bugiani O; Tagliavini F
Neurobiol Aging; 2008 Dec; 29(12):1864-73. PubMed ID: 17560687
[TBL] [Abstract][Full Text] [Related]
14. [Gerstmann-Straüssler-Scheinker syndrome].
Tranchant C; Warter JM
Rev Neurol (Paris); 1998 Feb; 154(2):152-7. PubMed ID: 9773036
[TBL] [Abstract][Full Text] [Related]
15. [Neuropathology of non conventional infectious agents or prions].
Hauw JJ; Naccache PY; Seilhean D; Camilleri S; Mokhtari K; Duyckaerts C
Pathol Biol (Paris); 1995 Jan; 43(1):43-52. PubMed ID: 7777377
[TBL] [Abstract][Full Text] [Related]
16. [Neuronal apoptosis in human prion diseases].
Gray F; Adle-Biassette H; Chrétien F; Ereau T; Delisle MB; Vital C
Bull Acad Natl Med; 1999; 183(2):305-20; discussion 320-1. PubMed ID: 10371778
[TBL] [Abstract][Full Text] [Related]
17. Neuropathologic characteristics of spinal cord lesions in sporadic Creutzfeldt-Jakob disease.
Iwasaki Y; Yoshida M; Hashizume Y; Kitamoto T; Sobue G
Acta Neuropathol; 2005 Nov; 110(5):490-500. PubMed ID: 16175355
[TBL] [Abstract][Full Text] [Related]
18. Early neurophysiological biomarkers and spinal cord pathology in inherited prion disease.
Rudge P; Jaunmuktane Z; Hyare H; Ellis M; Koltzenburg M; Collinge J; Brandner S; Mead S
Brain; 2019 Mar; 142(3):760-770. PubMed ID: 30698738
[TBL] [Abstract][Full Text] [Related]
19. Prions and prion diseases of the central nervous system.
Tyler KL
Curr Clin Top Infect Dis; 1999; 19():226-51. PubMed ID: 10472489
[No Abstract] [Full Text] [Related]
20. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies.
Pocchiari M; Puopolo M; Croes EA; Budka H; Gelpi E; Collins S; Lewis V; Sutcliffe T; Guilivi A; Delasnerie-Laupretre N; Brandel JP; Alperovitch A; Zerr I; Poser S; Kretzschmar HA; Ladogana A; Rietvald I; Mitrova E; Martinez-Martin P; de Pedro-Cuesta J; Glatzel M; Aguzzi A; Cooper S; Mackenzie J; van Duijn CM; Will RG
Brain; 2004 Oct; 127(Pt 10):2348-59. PubMed ID: 15361416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
